Can BPC-157 Speed Up Healing and Slow Down Aging?

What the “Body Protection Compound” Could Mean for Regeneration and Longevity

Four active women over 40 exercising outdoors: running, yoga and tennis
Editorial Disclosure

BeMediq Journal is published by BeMediq Care, a health and wellness platform offering a range of treatments including hormone therapy, weight management and cellular health programs. BeMediq Journal evaluates the scientific evidence independently of products and services offered through BeMediq Care. Research discussed here should not be interpreted as evidence that a specific BeMediq treatment produces the same effects unless explicitly stated and supported by evidence specific to that treatment.

Elena Brull

Elena Brull

Women's Health & Functional Nutrition Research Writer · November 19, 2026 · 10 min read

Many of us know this moment. You make a plan to exercise regularly, with a run in the morning and a yoga class twice a week. For a few weeks it works beautifully. Running feels a little easier each week, and the new routine finally sticks. Then, one morning, the back of your heel starts to hurt. It is your Achilles tendon. Now you can neither run nor do yoga. Sometimes it takes weeks before the tendon recovers.

Why can’t it heal any faster, you may wonder.

Tendon injuries like this heal slowly at any age. Many of us know it from our younger, sportier years. Over time, though, something changes. The tendons seem to complain sooner, and it takes longer before you can move freely again.[1]

What if something could already help your tendons heal faster? For more than 30 years, researchers have been studying a peptide that raises exactly this hope. Its name is BPC-157. In Part 1, we followed the peptide from its discovery in gastric juice into the lab. Now we ask whether BPC-157 could help the body heal the way it once did, and perhaps even help us age more slowly.

Why Does Healing Slow Down With Age?

Tendons connect your muscles to your bones. They are built to be strong, but they contain few cells and few blood vessels.[2] Oxygen and building materials reach an injured tendon slowly, so even at 25, a strained tendon can take weeks or months to heal.

Over the years, tendons also change. Their collagen fibers, the protein strands that give them strength, become less orderly, and the tendon has fewer repair cells.[3] At the same time, sugar molecules slowly attach to the collagen and tie the fibers together more tightly.[4] This can make the tendon stiffer and less elastic. That may be one reason why tendons start to complain sooner as we get older.

Do you remember the three phases of healing from Part 1? The body first cleans up the injured area, then builds new tissue, and finally remodels it until it is strong again. Studies on skin wounds show that healing runs more slowly in older people.[5] Fewer new blood vessels grow into the injured area, for example, and new collagen is built more slowly. How much of this also applies to tendons has been studied far less.

If the body's repair work slows down with age, could we support it from the outside?This is the question regenerative medicine is trying to answer.

Why Can a Lizard Regrow Its Tail, but We Can't?

When a green anole lizard is caught by its tail, it can simply let the tail go and escape. Then it grows a new one.[14] Wouldn’t it be wonderful if our bodies could do the same with an injured Achilles tendon?

We humans cannot do this. Like most mammals, we usually heal injuries with scar tissue rather than regrowing what was lost.[15] There are a few exceptions. The liver can grow back to its original size even after about two-thirds of it has been surgically removed.[16] As we saw in Part 1, the cells lining the stomach are replaced every few days. Your Achilles tendon is not one of them. After an injury, tendons form a scar-like tissue that is weaker and less elastic than the original.[17]

Regenerative medicine wants to change that. This field aims to repair or replace damaged tissue so that it works normally again. For injuries of bones, joints and tendons, researchers are testing stem cells and platelet-rich plasma (PRP), a concentrate made from the patient’s own blood that is rich in growth factors.[18] Growth factors are signals that tell cells to multiply and rebuild tissue. Many of them are proteins. BPC-157 is much smaller and belongs to the peptides, the little relatives of proteins.

Doctors have been treating patients with peptides for more than 100 years. In 1922, insulin was an experimental extract that barely helped its first patient.[19] Today it is essential for millions of people with diabetes, and more than 80 peptide medicines have reached the market, over 30 of them since 2000.[20][21]

Since 1963, chemists have been able to build peptides in the lab, one amino acid at a time.[21] This allows scientists to copy the body’s own peptides and study what they do. Peptides fascinate them because the body uses peptides as messengers. Each peptide is a short chain of amino acids, and like a word, its sequence carries a specific message. Insulin, for example, tells cells to take up sugar from the blood. In Part 1, we described BPC-157 as a word with 15 letters, taken from the much larger protective protein BPC found in gastric juice. Researchers are investigating whether this word might carry a message about repair. How it would work is still unclear, and no receptor for BPC-157 has been identified.

Most of what we know about BPC-157 comes from animal studies, mostly in rats. They linked the peptide to faster healing of tendons, muscles and ligaments.[22][23] Remember the liver, which can grow back after surgery? The research group in Zagreb, Croatia, that developed BPC-157 tested it on the liver early on. In 1993, the same year their first paper on BPC-157 appeared, they gave it to rats with different kinds of liver damage. In these animals, BPC-157 protected liver cells from dying and prevented fat from building up in the liver.[24]

These findings explain why so many people are interested in BPC-157. Yet the history of medicine has a sobering side. For every insulin, there are many substances that looked promising in animals and failed in people.[25] How BPC-157 has fared in people is the subject of Part 4 of our series.

Suppose BPC-157 really helped an injured tendon heal faster. Would that also mean we age in better health?

Is Faster Healing the Same as Slower Aging?

At first glance, healing and aging seem closely linked. Wounds heal more slowly as we get older, so a substance that speeds up healing might also slow down aging. But the two are not the same.

Healing is the body's answer to a specific injury. Aging, by contrast, happens throughout the body, often without any injury at all. Researchers describe it as the gradual loss of function in our cells and tissues, and a widely cited overview lists twelve typical features of aging.[26]

These changes take place on several levels. Deep inside each cell, damage to the genetic material builds up. The protective caps at the ends of our chromosomes, called telomeres, become shorter, and the mitochondria, the tiny power plants of the cell, produce energy less efficiently. Some cells stop dividing for good, and the stem cells that replace worn-out tissue slowly run out.[26]

At the level of the whole body, the way cells talk to each other changes too.[26] Hormones and other messengers carry this conversation. Some of them are peptides, like insulin, the messenger that helps cells take up sugar. Others, like estrogen, are made from cholesterol.[27] After menopause, estrogen levels fall, as described in the box above. The signals around insulin are among the most closely studied pathways in aging research.[26]

In the language of Part 1, aging involves many different words. BPC-157 may be one word that means something like “repair.” Most of the words that shape how we age have little to do with healing an injury.

Longevity research therefore asks a bigger question than how fast a wound closes. It wants to know whether people stay healthy for longer. Researchers call this the healthspan, meaning the years we live in good health and not just the number of years.

A rat tendon that heals faster tells us little about either. We found no published evidence that BPC-157 slows biological aging or extends normal lifespan, in people or in animals. The closest is a short conference report from 2018. Researchers gave fruit flies hydrogen peroxide, a substance that damages cells, and tested whether BPC-157 helped them survive.[28] That is a question about surviving poisoning, not about aging.

Can Repair Signals Go Too Far?

There is a second reason why faster repair is not automatically better. The signals that drive repair tell cells to divide and new blood vessels to grow. That is exactly what an injured tendon needs, but tumors also depend on new blood vessels to grow.[22]

The liver shows how close these two sides are. One of its most important repair signals is a large protein called hepatocyte growth factor (HGF). It helps the liver grow back, but it also strongly promotes the growth of new blood vessels and can fuel tumor growth.[29] Because the risk of cancer rises steadily with age,[30] this question matters most for the very people who are interested in longevity.

For BPC-157, the picture is unclear.In animal studies, it encouraged the growth of new blood vessels, so some experts see a theoretical risk that it could also support unwanted growth.[31] Yet one early laboratory study on human skin cancer cells reported the opposite. In this study, BPC-157 slowed the growth of the cancer cells.[32] It was only a short conference report, but it shows why this question deserves careful research. There is no evidence that BPC-157 causes cancer in people. But the studies in people are far too small and too short to show whether it is safe in the long term. We will look at what is known about the safety of BPC-157 in Part 4.

What would it take to show that BPC-157 helps people heal, or even age in better health?

Researchers would need studies in which people are randomly assigned to receive either BPC-157 or a placebo, without knowing which one they get. For healing, a randomized, double-blind, placebo-controlled Phase 2 trial began in February 2026. It is testing BPC-157 in 120 planned adults with acute hamstring strains.[33] According to the trial registry, the study is recruiting, and no results are available yet. For aging, studies would have to run for many years and measure whether people stay healthy for longer. No such study exists for BPC-157.

What Helps an Injured Tendon Today?

So what can you do today when your Achilles tendon hurts and your running shoes stay in the closet? For now, the most reliable help is less exciting than a new peptide. If the pain comes from overuse, doctors speak of Achilles tendinopathy. For this, the best-supported treatment is an exercise program that loads the tendon a little more step by step, often guided by a physiotherapist.[34] Recovery takes patience, often weeks or months, because tendons adapt slowly. Sudden sharp pain, a popping sound or trouble walking are different. They can be signs of a torn tendon and need medical care right away.[35]

Strength training also helps beyond the injury. Tendons respond to regular loading, and resistance training can make them stronger.

What about BPC-157? A US doctor who offers the peptide in his practice has published small reports in which patients described improvements.[36][37] But these studies had no comparison group, so they cannot show whether BPC-157 made the difference or whether symptoms improved for other reasons. In 2026, researchers reviewed all published studies in people. They found only three small studies with 30 participants in total and rated the evidence as very weak.[38] For now, BPC-157 remains an experimental peptide, not an established treatment for tendon injuries. Anyone thinking about trying it should talk to a doctor first.

FAQ

Frequently asked questions

Can BPC-157 speed up healing?

In animal studies, mostly in rats, BPC-157 was linked to faster healing of tendons, muscles and ligaments. Whether it does the same in people is still unknown. A 2026 review found only three small studies in people, with 30 participants in total, and rated the evidence as very weak.

Why do injuries heal more slowly as we get older?

With age, the body's repair work slows down. Studies of skin wounds show that healing tends to take longer in older people. Tendons heal slowly at any age. After an injury, they form a scar-like tissue that is weaker and less elastic than the original.

Does menopause affect healing?

Estrogen helps the skin and connective tissue produce collagen. After menopause, estrogen levels drop, the skin loses collagen, and wounds begin to heal more slowly. Muscle and joint pain also become more common during and after the transition. Before menopause, women have tendon problems less often than men. After menopause, this advantage disappears.

Can hormone therapy help injured tendons heal?

That has not been shown. Hormone therapy is not a treatment for tendon injuries. It is mainly used for hot flashes and other menopause symptoms and to protect the bones. In a small study, women who took estrogen after menopause built new tendon collagen faster, but healing was not tested. If you are considering hormone therapy, you can discuss collagen and healing with your doctor.

Can BPC-157 slow down aging?

We found no published evidence that BPC-157 slows biological aging or extends lifespan, in people or in animals. The closest is a short 2018 conference report on fruit flies exposed to a substance that damages cells. It looked at surviving poisoning, not at aging.

Is faster healing the same as slower aging?

No. Healing is the body's answer to a specific injury. Aging happens throughout the body, often without any injury. It affects the genetic material, the energy production in our cells and the way cells talk to each other. Longevity research asks whether people stay healthy for longer. Researchers call this the healthspan.

Can BPC-157 cause cancer?

There is no evidence that BPC-157 causes cancer in people. In animal studies, it encouraged the growth of new blood vessels, so some experts see a theoretical risk that it could support unwanted growth. One early laboratory study on skin cancer cells reported the opposite. The studies in people are far too small and too short to show whether BPC-157 is safe in the long term.

Are there clinical trials on BPC-157?

Yes. A randomized, double-blind, placebo-controlled Phase 2 trial began in February 2026. It is testing BPC-157 in 120 planned adults with acute hamstring strains. According to the trial registry, the study is recruiting, and no results are available yet. There are no long-term studies on BPC-157 and aging.

What helps an injured Achilles tendon today?

If the pain comes from overuse, the best-supported treatment is an exercise program that loads the tendon a little more step by step, often guided by a physiotherapist. Recovery often takes weeks or months. Sudden sharp pain, a popping sound or trouble walking can be signs of a torn tendon and need medical care right away.

Should I try BPC-157 for a tendon injury?

BPC-157 remains an experimental peptide, not an established treatment for tendon injuries. A US physician has published reports in which patients described improvements, but these studies had no comparison group. Anyone thinking about trying BPC-157 should talk to a doctor first.

References

  1. Gould L, Abadir P, Brem H, et al. Chronic wound repair and healing in older adults: current status and future research. J Am Geriatr Soc. 2015;63(3):427–38. doi:10.1111/jgs.13332
  2. Schulze-Tanzil GG, Delgado Cáceres M, Stange R, Wildemann B, Docheva D. Tendon healing: a concise review on cellular and molecular mechanisms with a particular focus on the Achilles tendon. Bone Joint Res. 2022;11(8):561–74. PMCID: PMC9396922
  3. Kwan KYC, Ng KWK, Rao Y, et al. Effect of aging on tendon biology, biomechanics and implications for treatment approaches. Int J Mol Sci. 2023;24(20):15183. PMCID: PMC10607611
  4. Svensson RB, Heinemeier KM, Couppé C, Kjaer M, Magnusson SP. Effect of aging and exercise on the tendon. J Appl Physiol. 2016;121(6):1237–46. PMID: 27150831
  5. Gosain A, DiPietro LA. Aging and wound healing. World J Surg. 2004;28(3):321–6. doi:10.1007/s00268-003-7397-6
  6. Calleja-Agius J, Muscat-Baron Y, Brincat MP. Skin ageing. Menopause Int. 2007;13(2):60–4.
  7. Campbell L, Emmerson E, Davies F, et al. Estrogen promotes cutaneous wound healing via estrogen receptor β independent of its antiinflammatory activities. J Exp Med. 2010;207(9):1825–33. PMCID: PMC2931162
  8. Ashcroft GS, Greenwell-Wild T, Horan MA, Wahl SM, Ferguson MW. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol. 1999;155(4):1137–46.
  9. Kruse C, McKechnie T, Dworsky-Fried J, et al. Musculoskeletal manifestations of perimenopause: a systematic review and meta-analysis of 93,021 women. JBJS Open Access. 2026;e25.00254. doi:10.2106/JBJS.OA.25.00254
  10. Wright VJ, Schwartzman JD, Itinoche R, Wittstein J. The musculoskeletal syndrome of menopause. Climacteric. 2024;27(5):466–72. doi:10.1080/13697137.2024.2380363
  11. Frizziero A, Vittadini F, Gasparre G, Masiero S. Impact of oestrogen deficiency and aging on tendon: concise review. Muscles Ligaments Tendons J. 2014;4(3):324–8. PMCID: PMC4241423
  12. Hansen M, Kongsgaard M, Holm L, et al. Effect of estrogen on tendon collagen synthesis, tendon structural characteristics, and biomechanical properties in postmenopausal women. J Appl Physiol. 2009;106(4):1385–93.
  13. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767–94. PMID: 35797481
  14. Ritzman TB, Stroik LK, Julik E, et al. The gross anatomy of the original and regenerated tail in the green anole (Anolis carolinensis). Anat Rec. 2012;295(10):1596–608.
  15. National Institutes of Health. Lizard tails give clues to cartilage formation. NIH Research Matters. 2023 Aug 22. Available from: nih.gov
  16. Yagi S, Hirata M, Miyachi Y, Uemoto S. Liver regeneration after hepatectomy and partial liver transplantation. Int J Mol Sci. 2020;21(21):8414. PMCID: PMC7665117
  17. Tsai SL, Nödl MT, Galloway JL. Bringing tendon biology to heel: leveraging mechanisms of tendon development, healing, and regeneration to advance therapeutic strategies. Dev Dyn. 2021;250(3):393–413. PMCID: PMC8486356
  18. Eskandar K. Stem cells, PRP, and bioprinting: advancements in regenerative medicine for orthopedic disorders. Rev Osteoporos Metab Miner. 2025;17(2):90–100. doi:10.20960/RevOsteoporosMetabMiner.00078
  19. University of Toronto Libraries. The discovery and early development of insulin: patients. Available from: collections.library.utoronto.ca
  20. Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nat Rev Drug Discov. 2021;20(4):309–25. Available from: nature.com
  21. Wang L, Wang N, Zhang W, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022;7(1):48. PMCID: PMC8844085
  22. McGuire FP, Martinez R, Lenz A, Skinner L, Cushman DM. Regeneration or risk? A narrative review of BPC-157 for musculoskeletal healing. Curr Rev Musculoskelet Med. 2025;18(12):611–9. PMCID: PMC12446177
  23. Staresinic M, Sebecic B, Patrlj L, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976–83.
  24. Sikiřić P, Seiwerth S, Grabarević Z, et al. Hepatoprotective effect of BPC 157, a 15-amino-acid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CCl4 administration. A comparative study with dopamine agonists and somatostatin. Life Sci. 1993;53(18):PL291–6.
  25. Sun D, Gao W, Hu H, Zhou S. Why 90% of clinical drug development fails and how to improve it? Acta Pharm Sin B. 2022;12(7):3049–62.
  26. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243–78. PMID: 36599349
  27. Chidi-Ogbolu N, Baar K. Effect of estrogen on musculoskeletal performance and injury risk. Front Physiol. 2019;9:1834. PMCID: PMC6341375
  28. Stable gastric pentadecapeptide BPC 157 antagonizes hydrogen peroxide induced oxidative stress in Drosophila melanogaster. FASEB J. 2018;32(1 Suppl). Meeting abstract.
  29. Zhao Y, Ye W, Wang YD, Chen WD. HGF/c-Met: a key promoter in liver regeneration. Front Pharmacol. 2022;13:808855. doi:10.3389/fphar.2022.808855
  30. National Cancer Institute. Age and cancer risk. Available from: cancer.gov
  31. Singh S, Pino MA. Heal or harm? Body Protective Compound-157 in the gray zone. Pharmacy Times. 2026 Jul 1. Available from: pharmacytimes.com
  32. Radeljak S, Seiwerth S, Sikiric P. BPC 157 inhibits cell growth and VEGF signalling via the MAPK kinase pathway in the human melanoma cell line. Melanoma Res. 2004;14:A14–5. Meeting abstract.
  33. ClinicalTrials.gov. A randomized, double-blind, placebo-controlled phase 2 trial of pentadecapeptide BPC 157 for accelerated repair of acute grade II hamstring strain confirmed by MRI (BPC-HAMSTR). Identifier NCT07437547. Bethesda (MD): National Library of Medicine (US); 2026 [cited 2026 Nov 20]. Available from: clinicaltrials.gov
  34. Chimenti RL, Neville C, Houck J, Cuddeford T, Carreira D, Martin RL. Achilles pain, stiffness, and muscle power deficits: midportion Achilles tendinopathy revision – 2024. J Orthop Sports Phys Ther. 2024;54(12):CPG1–CPG32. doi:10.2519/jospt.2024.0302
  35. NHS Ayrshire and Arran. Achilles tendon rupture. Right Decisions. Available from: rightdecisions.scot.nhs.uk
  36. Lee E, Padgett B. Intra-articular injection of BPC 157 for multiple types of knee pain. Altern Ther Health Med. 2021;27(4):8–13. PMID: 34324435
  37. Lee E, Walker C, Ayadi B. Effect of BPC-157 on symptoms in patients with interstitial cystitis: a pilot study. Altern Ther Health Med. 2024;30(10):12–7. PMID: 39325560
  38. Poolton JT, Minett J, Kazmi A. Human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safety. Acta Orthop Belg. 2026;92(3). doi:10.52628/92.3.15837

‍

Medical & Editorial Disclaimer

Content published by BeMediq Journal is provided for educational and informational purposes only. It may discuss scientific research, health, wellness, aging, beauty, lifestyle, and related topics, but is not intended to provide medical advice, diagnosis, or treatment, or to replace consultation with a qualified healthcare professional.

Scientific evidence evolves, and research findings may be preliminary, observational, conflicting, or subject to different interpretations. References to studies, biological mechanisms, associations, or potential benefits should not be understood as establishing that the same findings apply to every individual or as demonstrating clinical effectiveness unless specifically supported by the evidence discussed.

Editorial analysis, interpretations, perspectives, and opinions presented by BeMediq Journal are intended to provide context and encourage informed discussion. Where scientific evidence and editorial interpretation intersect, we aim to distinguish established findings from emerging evidence, hypotheses, and our editorial perspective.

Decisions concerning your health, medications, treatments, supplements, or other medical care should be made in consultation with an appropriately qualified healthcare professional.

‍

‍

‍

Written by Elena Brull, Women’s Health & Functional Nutrition Research Writer (ORCID: 0009-0009-3547-6731)

About the Author

Elena Brull is a Women’s Health and Functional Nutrition Research Writer covering women’s health, nutrition, metabolic health, hormonal transitions, and longevity. Her work examines scientific research, emerging evidence, and the connections between them to help women better understand their biology and the questions worth asking about it. She writes from a non-clinical, educational perspective — with the intention to inform and empower, not to diagnose or prescribe.

‍

Our Editorial Standards

‍

License:
© 2026 BeMediq.
This article is published under a
Creative Commons Attribution–NonCommercial–NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Educational sharing is permitted; commercial use or modification requires written permission from the author and BeMediq.

‍

‍

EDITORIAL DISCLOSURE

BeMediq Care offers products or services related to the topic discussed in this article. BeMediq Journal evaluates the scientific evidence independently of products and services offered through BeMediq Care. Research discussed here should not be interpreted as evidence that a specific BeMediq product or service produces the same effects unless explicitly stated and supported by evidence specific to that product or service.

‍

────────────

FROM BEMEDIQ CARE · COMMERCIAL

Explore BeMediq Care

BeMediq Care offers access to health and wellness services separate from the editorial content of BeMediq Journal.

‍

‍

Discover Products to Support Your Health & Well-Being

Science Spotlight

Curious About the Science behind this Article?

BeMediq Science Spotlight icon